Literature DB >> 11279138

The conformation of the glucocorticoid receptor af1/tau1 domain induced by osmolyte binds co-regulatory proteins.

R Kumar1, J C Lee, D W Bolen, E B Thompson.   

Abstract

The activation domains of many transcription factors appear to exist naturally in an unfolded or only partially folded state. This seems to be the case for AF1/tau1, the major transactivation domain of the human glucocorticoid receptor. We show here that in buffers containing the natural osmolyte trimethylamine N-oxide (TMAO), recombinant AF1 folds into more a compact structure, as evidenced by altered fluorescence emission, circular dichroism spectra, and ultracentrifugal analysis. This conformational transition is cooperative, a characteristic of proteins folding to natural structures. The structure resulting from incubation in TMAO causes the peptide to resist proteolysis by trypsin, chymotrypsin, endoproteinase Arg-C and endoproteinase Gluc-C. Ultracentrifugation studies indicate that AF1/tau1 exists as a monomer in aqueous solution and that the presence of TMAO does not lead to oligomerization or aggregation. It has been suggested that recombinant AF1 binds both the ubiquitous coactivator CBP and the TATA box-binding protein, TBP. Interactions with both of these are greatly enhanced in the presence of TMAO. Co-immunoadsorption experiments indicate that in TMAO each of these and the coactivator SRC-1 are found complexed with AF1. These data indicate that TMAO induces a conformation in AF1/tau1 that is important for its interaction with certain co-regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279138     DOI: 10.1074/jbc.M100825200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Thermodynamic dissection of the intrinsically disordered N-terminal domain of human glucocorticoid receptor.

Authors:  Jing Li; Hesam N Motlagh; Carolyn Chakuroff; E Brad Thompson; Vincent J Hilser
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

Review 2.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

Review 3.  Chromatin dynamics and the evolution of alternate promoter states.

Authors:  Gordon L Hager; Cem Elbi; Thomas A Johnson; Ty Voss; Akhilesh K Nagaich; R Louis Schiltz; Yi Qiu; Sam John
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

Review 4.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

Review 5.  Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges.

Authors:  S Stoney Simons; Dean P Edwards; Raj Kumar
Journal:  Mol Endocrinol       Date:  2013-11-27

Review 6.  Allosteric pathways in nuclear receptors - Potential targets for drug design.

Authors:  Elias J Fernandez
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

Review 7.  Intrinsically disordered proteins and their environment: effects of strong denaturants, temperature, pH, counter ions, membranes, binding partners, osmolytes, and macromolecular crowding.

Authors:  Vladimir N Uversky
Journal:  Protein J       Date:  2009-10       Impact factor: 2.371

Review 8.  Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors.

Authors:  Vincent J Hilser; E Brad Thompson
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

9.  Disordered allostery: lessons from glucocorticoid receptor.

Authors:  Hesam N Motlagh; Jeremy A Anderson; Jing Li; Vincent J Hilser
Journal:  Biophys Rev       Date:  2015-04-23

Review 10.  Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation.

Authors:  Robert D Ward; Nancy L Weigel
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.